SCHEMBL24327976

SCHEMBL24327976

Nc1ncc(-c2ccc(Cl)cc2)nc1-c1cnn(C2CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.52
FGFR2 P21802 14/20 0.52
FGFR3 P22607 14/20 0.52
EGFR P00533 2/20 0.48
MAP4K3 Q8IVH8 2/20 0.46
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
PI4KA P42356 1/20 0.43
PIK3CG P48736 1/20 0.43
PI4KB Q9UBF8 1/20 0.43
MET P08581 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24327856 0.85 EGFR (0.46) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL29498954 0.85 EGFR (0.46) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL24327827 0.82 FGFR3 (0.53) FGFR1FGFR2FGFR3
SCHEMBL24327834 0.78 PIK3CD (0.43) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL29498917 0.75 FGFR1 (0.39) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL24327989 0.75 FGFR1 (0.39) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL4043377 0.72 EGFR (0.78) FGFR1FGFR2FGFR3EGFR
SCHEMBL31515717 0.71 PIK3CD (0.45) FGFR1FGFR2FGFR3EGFRMAP4K3
SCHEMBL24327855 0.70 LRRK2 (0.58) FGFR1FGFR2FGFR3
SCHEMBL24327947 0.70 FGFR3 (0.48) FGFR1FGFR2FGFR3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114369097-B Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2023-07-14 CN disclosed
WO-2022078356-A1 HETEROAROMATIC AHR INHIBITOR 山东轩竹医药科技有限公司 2022-04-21 WO disclosed
WO-2022078356-A1 HETEROAROMATIC AHR INHIBITOR 山东轩竹医药科技有限公司 2022-04-21 WO disclosed
CN-114369097-A Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2022-04-19 CN disclosed